[1] Brightling, C.; Greening, N. Airway inflammation in COPD: progress to precision medicine. Eur. Respir. J. 2019,54,1900651.
[2] Mcgeachie, M.J.; Sordillo, J.E.; Dahlin, A.; Wang, A.L.; Lutz,S.M.; Tantisira,K.G.; Panganiban, R.; Lu,Q.; Sajuthi, S.; Urbanek, C.; Kelly,R.; Saef, B.; Eng,C.; Oh,S.S.; Kho,A.T.; Croteau-Chonka,D.C.; Weiss,S.T.; Raby,B.A.; Mak, A.C.Y.; Rodriguez-Santana, J.R.; Burchard,E. G.; Seibold,M. A.; Wu, A. C. Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy. Respir. Res. 2020, 21, 31.
[3] Navanandan, N.; Moran, E.; Smith,H.; Hoch,H.; Mistry, RD. Primary care provider preferences for glucocorticoid management of acute asthma exacerbations in children. J. Asthma. 2021,58,547-553
[4] Reddy, A. T. ; Lakshmi, S. P. ; Banno, A. ; Reddy, R. C. Glucocorticoid Receptor α Mediates Roflumilast’s Ability to Restore Dexamethasone Sensitivity in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2020, 15,125-134.
[5] Ko, F.; Sin, D. D. Twenty-five years of Respirology: Advances in COPD. Respirology 2020, 25, 17-19.
[6] Global Initiative for Chronic Obstructive Lung Disease [webpage on the internet]. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [ updated 2020; Accessed November 15, 2019 Available from https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf]
[7] Sapey, E.; Stockley, R.A. Getting stuck or choosing to stay? Neutrophil transit times in the lung in acute inflammation and COPD. Thorax 2019, 74, 631-632.
[8] Knobloch, J.; Jungck, D.; Kronsbein, J.; Stoelben, E.; Ito, K.; Koch, A. LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD. J.Clin.Med. 2019, 8, 2058.
[9] Mei, D.; Tan, W.; Wong, W. Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD. Curr. Opin. Pharmacol. 2019, 46,73-81.
[10] Li, K. ; Tao, N. ; Zheng, L. ; Sun, T. LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lung [J]. Int. Immunopharmacol. 2020, 79:106057.
[11] Zhu, M. ; Ye, M. ; Wang, J. ; Ye, L. ; Jin, M. Construction of Potential miRNA–mRNA Regulatory Network in COPD Plasma by Bioinformatics Analysis. Int. J. Chron. Obstruct. Pulmon. Dis.2020,15,2135-2145.
[12] Hobbs, B.D.; Tantisira, K.G. MicroRNAs in COPD: small molecules with big potential. Eur. Respir. J. 2019, 53,1900515.
[13] Tang, H.; Mao, J.; Ye, X.; Zhang, F.; Kerr, W.G.; Zheng, T.; Zhu, Z. SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis . FASEB. J. 2020, 34, 2011-2023.
[14] Roffel, M. P. ; Bracke, K.R. ; Heijink, I. H. ; Maes, T.miR-223: A Key Regulator in the Innate Immune Response in Asthma and COPD. Front. Med(Lausanne). 2020,7,196.
[15] Kim , R. Y.; Horvat, J. C.; Pinkerton, J. W.; Starkey, M. R.; Essilfie, A. T.; Mayall, J. R.; Nair, P. M.; Hansbro, N. G.; Jones, B.; Haw, T. J. MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2. J. Allergy. Clin. Immunol. 2017, 139,519-532.
[16] Guo, Q.; Li, L.; Zheng ,K.; Zheng, G.; Shu, H.; Shi, Y.; Lu, C.; Shu, J.; Guan, D.; Lu, A.; He, X. Imperatorin and β-sitosterol have synergistic activities in alleviating collagen-induced arthritis. J. Leukoc. Biol. 2020,108,509-517.
[17] Zhang, X. ; Zhu, J. ; Yan, J. ; Xiao, Y.; Yang, R.; Huang, R.; Zhou, J.; Wang, Z.; Xiao, W.; Zheng, C.; Wang, Y. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer. Phytomedicine 2020,79,153326.
[18] Wu,J.; Li,X.; Qin, Y.; Cheng, J.; Hao, G.; Jin, R.; Zhu, C. Jinwei Decoction modulates HDAC2 expression in a rat model of COPD. Exp. The.r Med. 2018, 15, 2604-2610.
[19] Mitani, A.; Azam, A.; Vuppusetty, C. ; Ito, K. ; Mercado, N. ; Barnes, P. J. Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease. Exp. Lung. Res. 2017,43,1-9.
[20] Lakshmi, S. P.; Reddy, A. T.; Kodidhela, L. D.; Varadacharyulu, N. C. Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells. Life Sci.2020,259,118260.
[21] Tsou, Y. A.; Huang, H. J. ; Lin, W. Y. ; Chen, Y. C. Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine. Evidence-Based Complementary Altern.Med.2014,4,465025.
[22] Vanderstocken, G. ; Dvorkin-Gheva, A. ; Shen, P. ; Brandsma, C. A. ; Stampfli, M. R.Identification of Drug Candidates to Suppress Cigarette Smoke-induced Inflammation via Connectivity Map Analyses. Am. J. Respir. Cell. Mol. Biol. 2018,58,727-735.
[23] Tang, W. H. ; Zhu, R. H. ; Li, Y. H. ; Liu, Z. F. ; Wan, T. The effect of luteolin on concentration of TNF-α and pulmonary function in patients with chronic obstructive pulmonary disease. China Journal of Modern Medicine.2012,22,64-67.
[24] Cao, G.; Li,S. Effect of baicalein on LTC4 level in arterial plasma of patients with chronic obstructive pulmonary disease. Journal of Bethune Medical University 1994,20,589-590.
[25] Wei, Q. Therapeutic effect and mechanism of quercetin on bleomycin induced pulmonary fibrosis in rats. Shandong University 2017.
[26] Pratheeshkumar, P.; Son, Y. O.; Divya, S. P., Lei, W.; Shi, X. Quercetin inhibits Cr (VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget 2017,8,52118.
[27] Zhou, Y. Molecular mechanism of EGCG on bleomycin induced pulmonary fibrosis in rats. Suzhou University 2012.
[28] Ahmed, F. ; Ijaz, B. ; Ahmad, Z. ; Farooq, N. ; Husnain, T. Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance. Phytomedicine 2020,68,153168.
[29] Chen, J.; Du, L.; Li ,J.; Song, H. Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis. Food. Chem. Toxicol.2016,96,70-78.
[30] Huang, J.; Qi, Z. MiR-21 mediates the protection of kaempferol against hypoxia/reoxygenation-induced cardiomyocyte injury via promoting Notch1/PTEN/AKT signaling pathway. PloS one 2020,15(11):e0241007.
[31] Zhu, G. ; Liu, X. ; Li, H. ; Yan, Y.; Hong, X. ; Lin, Z. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21. Int. J. Immunopathol. Pharmacol.2018,32,1-12.
[32] Kim, K. ; Kim, S. ; Sang, H. M. ; Kang, H. Kaempferol inhibits vascular smooth muscle cell migration by modulating BMP-mediated miR-21 expression. Mol. Cell. Biochem.2015,407,143-149.
[33] Zhang, Z.; Xu, P.; Yu, H.; Shi ,L. Luteolin protects PC-12 cells from H2O2 -induced injury by up-regulation of microRNA-21. Biomed. Pharmacother. 2019,112,108698.
[34] Gao, Y. ; Lu, J. ; Zhang, Y. ; Chen, Y. ; Gu, Z.; Jiang, X. Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21. Pulm. Pharmacol. Ther.2013,26, 649-654.
[35] Cui, X.; Sun, X.; Lu ,F.; Jiang, X. Baicalein represses TGF-β1-induced fibroblast differentiation through the inhibition of miR-21. Toxicol. Appl. Pharmacol. 2018,358,35-42.
[36] Stokes, C. A. ; Condliffe, A. M. Phosphoinositide 3-kinase δ (PI3Kδ) in respiratory disease. Biochem. Soc. Trans.2018,46,361-369.
[37] Sun, X.; Chen, L.; He, Z. PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease. Curr. Drug. Metab. 2019,20,301-304.
[38] Barnes, P. J.; Baker, J.; Donnelly, L. E. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. Am. J. Respir. Crit. Care. Med. 2019,200,556-564.
[39] Sun, X. J. ; Li, Z. H. ; Zhang, Y. ; Zhou, G. ; Zhang, J. Q. ; Deng, J. M. Bai, J.; Liu, G.; Li, M.; MacNee , W.; Zhong, X.; He, Z. Combination of erythromycin and 1 dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2015,309,L139-146.
[40] Cottage, C. T. ; Peterson, N. ; Kearley, J. ; Berlin, A. ; Xiong, X. ; Huntley, A.; Zhao, W.; Brown,C.; Migneault,A.; Zerrouki, K. Criner, G.; Kolbeck, R.; Connor, J.; Lemaire, R. Targeting p16-induced senescence prevents cigarette smoke-induced emphysema by promoting IGF1/Akt1 signaling in mice. Commun. Biol. 2019,2,307.
[41] Kneppers, A. ; Langen, R. ; Gosker, H. R. ; Verdijk, L. B. ; Lipovec, N. C. ; Leermakers, P. A.; Kelders, M.; Theije, C.; Omersa, D.; Lainscak, M.; Schols, A. Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia. J. Am. Med. Dir. Assoc. 2017,18, 637.e1-637.e11.
[42] Bin, Y. F. ; Ma, N. ; Lu, Y. X. ; Sun, X. J. ; Liang, Y. ; Bai, J.; Zhang, J.; Li,M.; Zhong, X.; He, Z. Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway. Free. Radic. Biol. Med. 2019,152, 494-503.
[43] Banerjee, A.; Koziol-White, C.; Panettieri, R. p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD. Curr. Opin. Pharmacol. 2012,12,287-292.
[44] Huang, C.; Xie, M. ; He, X. ; Gao, H. Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV1 in COPD patients. Med. Sci. Monit. 2013,19,1229-1235.
[45] Lapperre, T. S. ; Sont, J. K. ; Schadewijk, A. V. ; Gosman, M. M. ; Postma, D. S. ; Bajema, I. M.; Timens, Wim.; Mauad,T.; Hiemstra, P. Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir. Res. 2007,8,85.
[46] Nadel, J. A. ; Burgel, P. R. The role of epidermal growth factor in mucus production. Curr. Opin. Pharmacol. 2001,1,254-258.
[47] Zhang, H. X. ; Yang, J. J. ; Zhang, S. A. ; Zhang, S. M. ; Lin, R. Y.HIF-1α promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway. Ur. Rev. Med. Pharmacol. Sci. 2018,22,6077-6084.
[48] Lasithiotaki, I. ; Tsitoura, E. ; Koutsopoulos, A. ; Lagoudaki, E. ; Sourvinos, G.; Antoniou ,K. Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer. Oncotarget 2016,8,112371-112383.
[49] Liu, J. H. ; Li, C. ; Zhang, C. H. ; Zhang, Z. H.LncRNA-CASC7 enhances corticosteroid sensitivity via inhibiting the PI3K/AKT signaling pathway by targeting miR-21 in severe asthma. Pulmonology 2020,26,18-26.
[50] Liu, L.; Pan, Y.; Zhai, C.; Zhu, Y.; Ke, R.; Shi, W.; Wang, J.; Yan, X.; Su, X.; Song, y.; Gao, L.; Li, M. Activation of peroxisome proliferation–activated receptor‐γ inhibits transforming growth factor-β1-induced airway smooth muscle cell proliferation by suppressing Smad-miR-21 signaling. J. Cell. Physiol.2019,234,669-681.
[51] Wang, J. ; He, F. ; Chen, L. ; Li, Q. ; Jin, S. ; Zheng, H.; Lin, J.; Zhang, H.; MA, S.; Mei, J.; Yu, J. Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways. Biomed. Pharmacother. 2018,105,37-44.
[52] Marin, I. ; Ofek, E. ; Bar, J. ; Prisant, N. ; Perelman, M. ; Avivi, C. Lavy-Shahaf, G.; Onn, A.; Katz, R.; Barshack, I. MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study. J. Clin. Pathol. 2020,73,636-641.
[53] Barnes, P. J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy. Clin. Immunol. 2013,131,636-645.
[54] Osoata, G.; Yamamura, S.; Ito, M.; Vuppusetty, C.;, Adcock, I.M.; Barnes, P. J.; Ito, K. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem. Biophys. Res. Commun.2009,384,366-371.
[55] Han, M. K.; Barreto, T. A.; Martinez, F. J.; Comstock, A. T.; Sajjan, U. S. Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease. BMJ. Open. Respir. Res.2020,7,e000392.
[56] Lakshmi, S. P.; Reddy, A. T.; Kodidhela, L. D.; Varadacharyulu, N. C. Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells. Life. Sci. 2020,259,118260.
[57] Liang, Y.; Liu, K.; Yeung, S. C.; Li, X.; Ip, M.; Mak, J. (-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats. Front. Pharmacol.2017,8,618.
[58] Ueda, K.; Nishimoto, Y.; Kimura, G.; Masuko, T.; Barnes, P. J.; Ito, K.; Kizawa, Y. Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway. Biochem. Biophys. Rep.2016,7,367-373.
[59] Charron, C.; Chou, P.; Coutts, D.; Kumar, V.; To, M.; Akashi, K.; Pinhu, L.; Griffiths, M.; Adcock, I.; Barnes, Peter.J.; Ito, K. Hypoxia-inducible Factor 1α Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription. J. Biol. Chem.2009,284,36047-36054.
[60] Al-Rasheed, N. M.; Fadda, L. M.; Attia, H. A.; Ali, H. M.; Al-Rasheed, N. M. Quercetin inhibits sodium nitrite-induced inflammation and apoptosis in different rats organs by suppressing Bax, HIF1-α, TGF-β, Smad-2, and AKT pathways. J. Biochem. Mol. Toxicol.2017,31,1-7.
[61] Alcorn, J. F.; Crowe, C. R.; Kolls, J. K. TH17 Cells in Asthma and COPD. Annu. Rev. Physiol. 2010,72, 495-516.
[62] Song, Y.; Lu, H. Z.; Xu, J. R.; Wang, X. L.; Zhou, W.; Hou, L. N.; Liang, Z.; Yu, Z.H.; Chen, H. Z.; Cui, Y. Y. Carbocysteine restores steroid sensitivity by targeting histone deacetylase 2 in a thiol/GSH-dependent manner. Pharmacol. Res. 2015,91,88-98.
[63] Liu, T.; Wang, F. P.; Wang, G.; Mao, H. Role of Neutrophil Extracellular Traps in Asthma and Chronic Obstructive Pulmonary Disease. Chin. Med. J (Engl). 2017,130, 730-736.
[64] Cui, W.; Hu, G.; Peng, J.; Mu, L.; Liu, J.; Qiao, L. Quercetin Exerted Protective Effects in a Rat Model of Sepsis via Inhibition of Reactive Oxygen Species (ROS) and Downregulation of High Mobility Group Box 1 (HMGB1) Protein Expression. Med. Sci. Monit.2019,25,5795-5800.
[65] Chanjitwiriya, K.; Roytrakul, S.; & Kunthalert, D. Quercetin negatively regulates IL-1β production in Pseudomonas aeruginosa-infected human macrophages through the inhibition of MAPK/NLRP3 inflammasome pathways. PLoS One 2020,15,e0237752.
[66] Rajabi, S.; Najafipour, H.; Farsangi, S. J.; Joukar, S.; Kordestani, Z. Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway. BMC. Complement. Med. Ther.2020,20,218.
[67] Yuan, K.; Zhu, Q.; Lu, Q.; Jiang, H.; Zhu, M.; Li, X.; Huang, G.; Xu, A. Quercetin alleviates rheumatoid arthritis by inhibiting neutrophil inflammatory activities. J. Nutr. Biochem.2020,84,108454.
[68] Pan, F.; Zhu, L.; Lv, H.; Pei C. Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1. Int. J. Mol. Med.2016,38,1507-1514.
[69] Boadi, W. Y.; Lo, A. Effects of Quercetin, Kaempferol, and Exogenous Glutathione on Phospho- and Total-AKT in 3T3-L1 Preadipocytes. J. Diet. Suppl.2018,15, 814-826.
[70] Zeng, J.; Xu, H.; Fan, P.; Xie, J.; He, J.; Yu, J.; Gu, X.; Zhang, C. Kaempferol blocks neutrophil extracellular traps formation and reduces tumour metastasis by inhibiting ROS-PAD4 pathway. J. Cell. Mol. Med. 2020,24,7590-7599.
[71] Zhou, B. X.; Li, J.; Liang, X. L.; Pan, X. P.; Zhong, N. S. β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling. Acta. Pharmacol. Sin. 2020;41,1178-1196.
[72] Yang, N.; Shang, Y. Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model. Int. Immunopharmacol. 2019,72 ,422-428.
[73] Shan, L.; Kang, X.; Liu, F.; Cai, X.; Han, X.; Shang, Y. Epigallocatechin gallate improves airway inflammation through TGF-β1 signaling pathway in asthmatic mice. Mol. Med. Rep. 2018,18,2088-2096.
[74] Pei, R. L.; Ming, S. W.; Lee, C. K. Inhibitory Effects of Scutellaria baicalensis Root Extract on Linoleic Acid Hydroperoxide-induced Lung Mitochondrial Lipid Peroxidation and Antioxidant Activities. Molecules 2019,24,2143.